⌘K
Loading ticker…
Corcept Therapeutics Inc. · Healthcare · Pharmaceutical Products
As of 2026-06-26, Corcept Therapeutics Inc. (CORT) has a 3-month relative strength percentile of 97 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 67. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 4.7%, relative volume 1.60×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 97, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
CORT is held by 10 ETFs as of Mar 2026. Top owner: IJR at 0.25% weight, $227M notional. Top 3 carry $426M.
Top 10 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| IJRiShares Core S&P Small-Cap ETF | 0.25% | $227M |
| VTIVanguard Total Stock Market ETF | 0.01% | $115M |
| VBVanguard Small Cap ETF | 0.05% | $84M |
| VBKVanguard Small-Cap Growth ETF | 0.12% | $47M |
| VXFVanguard Extended Market ETF | 0.05% | $42M |
| IWFiShares Russell 1000 Growth ETF | 0.01% | $15M |
| IWRiShares Russell Midcap ETF | 0.03% | $15M |
| XPHState Street SPDR S&P Pharmaceuticals ETF | 2.29% | $7M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.01% | $5M |
| IWBiShares Russell 1000 ETF | 0.01% | $3M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CORT Jan avg: 6.22% median: 13.56% win: 75% σ: 28.98% n: 4 2022-04-12 → 2026-05-29 | CORT Feb avg: -4.36% median: -9.18% win: 25% σ: 10.51% n: 4 2022-04-12 → 2026-05-29 | CORT Mar avg: 28.16% median: 10.05% win: 100% σ: 40.43% n: 4 2022-04-12 → 2026-05-29 | CORT Apr avg: -7.13% median: -7.42% win: 40% σ: 19.63% n: 5 2022-04-12 → 2026-05-29 | CORT May avg: 17.56% median: 7.90% win: 80% σ: 21.50% n: 5 2022-04-12 → 2026-05-29 | CORT Jun avg: 2.79% median: 1.21% win: 50% σ: 9.72% n: 4 2022-04-12 → 2026-05-29 (current) | CORT Jul avg: 11.39% median: 16.77% win: 75% σ: 13.50% n: 4 2022-04-12 → 2026-05-29 | CORT Aug avg: 3.41% median: -2.46% win: 50% σ: 17.81% n: 4 2022-04-12 → 2026-05-29 | CORT Sep avg: 8.21% median: 9.25% win: 50% σ: 21.20% n: 4 2022-04-12 → 2026-05-29 | CORT Oct avg: 2.21% median: 4.44% win: 75% σ: 9.86% n: 4 2022-04-12 → 2026-05-29 | CORT Nov avg: 1.24% median: -0.61% win: 50% σ: 14.10% n: 4 2022-04-12 → 2026-05-29 | CORT Dec avg: -15.24% median: -16.15% win: 25% σ: 34.30% n: 4 2022-04-12 → 2026-05-29 |